Skip navigation
Why is this here?

Top story

iGEM 2013 Results

UK teams shined in iGEM 2013 competition

(read more...)

What they said

“We are reaching a key inflection point where advances in synthetic biology have the potential to rapidly accelerate and improve biotherapeutics drug discovery and development, from early-stage candidate discovery through product supply, which could bring better, more effective therapies to patients more rapidly”

Jose Carlos Gutierrez-Ramos, group senior vice president and head of Pfizer’s BioTherapeutics Research and Development, in MIT news

More notable quotations

Newsletter, February 2014

This month's newsletter highlights a number of upcoming events, including a symposium for early-career synthetic biologists being organized by Network members in Glasgow.<a href="">MB2-703</a>

Newsletter, February 2014 to view/download

The SynBioStandards Network is funded by these organisations:
Go to the website of the Arts and Humanities Research Council
Go to the website of the Biotechnology and Biological Sciences Research Council
Go to the website of the Economic and Social Research Council
Go to the website of the Engineering and Physical Sciences Research Council